Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vir Biotechnology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VIR
Nasdaq
8731
https://www.vir.bio/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vir Biotechnology Inc
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
- Mar 19th, 2024 6:58 pm
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
- Mar 13th, 2024 3:07 pm
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
- Mar 5th, 2024 1:05 pm
Q4 2023 Vir Biotechnology Inc Earnings Call
- Feb 23rd, 2024 6:54 pm
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 3:34 pm
Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade
- Feb 23rd, 2024 2:55 pm
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
- Feb 23rd, 2024 1:05 pm
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
- Feb 22nd, 2024 10:50 pm
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
- Feb 22nd, 2024 9:05 pm
Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
- Feb 20th, 2024 9:30 pm
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
- Feb 14th, 2024 8:45 pm
Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Trimmed Their Revenue Forecasts By 11%
- Feb 7th, 2024 10:09 am
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
- Feb 1st, 2024 9:05 pm
Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?
- Jan 3rd, 2024 3:32 pm
Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
- Dec 13th, 2023 9:05 pm
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
- Dec 6th, 2023 9:05 pm
7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
- Nov 30th, 2023 11:10 am
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
- Nov 13th, 2023 1:00 pm
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
- Nov 10th, 2023 1:00 pm
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
- Nov 8th, 2023 1:05 pm
Scroll